FDH served as legal counsel to Prelude Growth Partners in connection with its $20 million Series A strategic investment in OneSkin, Inc., a science driven skincare company founded by a team of female PhD scientists. OneSkin develops products rooted in longevity research and biotechnology rather than surface level solutions. Its proprietary OS 01 peptide is designed to address the causes of skin aging and support healthier, more resilient looking skin over time.
The completed deal was announced in a press release found here.
The FDH team included Corporate partner Skawenniio Barnes and Corporate associate Azadeh Amir-Aslani.